US clinical-research system in need of review

An imminent rethink is required on the country’s approach to government-supported health and pharmaceutical studies, says Arthur J. Ammann.

Nature 498 7 doi: 10.1038/498007a

Powered by WPeMatico

Share
This entry was posted in Science. Bookmark the permalink.

Comments are closed.